Skip to content

Evaluation of the Endometrial Cavity After Endometrial Ablation

Evaluation of the Endometrial Cavity After Endometrial Ablation

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02087228
Acronym
Postablation
Enrollment
25
Registered
2014-03-14
Start date
2013-09-30
Completion date
2015-07-31
Last updated
2016-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menorrhagia

Keywords

Endometrial ablation, menorrhagia

Brief summary

The purpose of this study is to evaluate the shape, size and appearance of the inside of the uterus six months following an endometrial ablation procedure. Half of the participants will have their ablation performed with a hydrothermal ablation device and the other half will have their ablation performed with a device that uses radiofrequency energy.

Detailed description

The purpose of this study is to evaluate the shape, size and appearance of the inside of the uterus six months following an endometrial ablation procedure. Half of the participants will have their ablation performed with a hydrothermal ablation device and the other half will have their ablation performed with a device that uses radiofrequency energy. Participants are randomly assigned to one or the other device. A vaginal ultrasound will be performed before the procedure and again at six months post-procedure. The inside of the uterus will be visualized via hysteroscopy before the procedure and again at six months post-procedure. Measurements will be taken and the investigator will compare photos taken pre-procedure and six months post-procedure.

Interventions

DEVICEGenesys HydroTherm Ablator

Heated water is circulated inside the uterus to destroy the lining of the uterus

DEVICEradiofrequency energy ablation device

Sponsors

Baylor Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 51 Years
Healthy volunteers
No

Inclusion criteria

* Premenopausal women Not pregnant and no future pregnancy desired Willing to randomize the device used for the ablation Willing to undergo diagnostic hysteroscopy with office-based anesthesia 6 months post-ablation

Exclusion criteria

* Pregnancy or desiring future pregnancy Endometrial hyperplasia Presence of active endometriosis Active pelvic inflammatory disease Previous endometrial ablation procedure

Design outcomes

Primary

MeasureTime frameDescription
Visualization of the inside of the uterus6 months post-ablationThe inside of the uterus will be visualized via hysteroscopy to determine the amount of scarring

Secondary

MeasureTime frameDescription
Measurments of endometrial thickness6 months post-ablationMeasurements will be taken of the uterine cavity length and endometrial thickness

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026